Correlation Between Abeona Therapeutics and Tonix Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abeona Therapeutics and Tonix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abeona Therapeutics and Tonix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abeona Therapeutics and Tonix Pharmaceuticals Holding, you can compare the effects of market volatilities on Abeona Therapeutics and Tonix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abeona Therapeutics with a short position of Tonix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abeona Therapeutics and Tonix Pharmaceuticals.

Diversification Opportunities for Abeona Therapeutics and Tonix Pharmaceuticals

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Abeona and Tonix is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Abeona Therapeutics and Tonix Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tonix Pharmaceuticals and Abeona Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abeona Therapeutics are associated (or correlated) with Tonix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tonix Pharmaceuticals has no effect on the direction of Abeona Therapeutics i.e., Abeona Therapeutics and Tonix Pharmaceuticals go up and down completely randomly.

Pair Corralation between Abeona Therapeutics and Tonix Pharmaceuticals

Given the investment horizon of 90 days Abeona Therapeutics is expected to generate 1.51 times less return on investment than Tonix Pharmaceuticals. But when comparing it to its historical volatility, Abeona Therapeutics is 2.81 times less risky than Tonix Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Tonix Pharmaceuticals Holding is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  17.00  in Tonix Pharmaceuticals Holding on August 31, 2024 and sell it today you would earn a total of  2.00  from holding Tonix Pharmaceuticals Holding or generate 11.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Abeona Therapeutics  vs.  Tonix Pharmaceuticals Holding

 Performance 
       Timeline  
Abeona Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Abeona Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Abeona Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Tonix Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Tonix Pharmaceuticals Holding are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Tonix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Abeona Therapeutics and Tonix Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abeona Therapeutics and Tonix Pharmaceuticals

The main advantage of trading using opposite Abeona Therapeutics and Tonix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abeona Therapeutics position performs unexpectedly, Tonix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tonix Pharmaceuticals will offset losses from the drop in Tonix Pharmaceuticals' long position.
The idea behind Abeona Therapeutics and Tonix Pharmaceuticals Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance